Other
Craniotomy
1
Pipeline Programs↗
0
Active Trials↗
2
Companies Involved↗
Craniotomy is an early-stage landscape with 1 program across 2 companies. The most active players are Kenvue Brands, Eli Lilly. 1 therapy is approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved1
Analysis
Trial Status
12
clinical trials
Completed12 · 100%
Clinical Trials
Trial Activity
12 trials
Desflurane and Brain Relaxation in Craniotomy
Completed·—·N/A·NCT04691128·111 enrolled
Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After Craniotomy
Completed·—·Phase 4·NCT02037815·35 enrolled
Comparison of Two Doses of Mannitol on Brain Relaxation During Supratentorial Craniotomy
Completed·—·N/A·NCT01048684·80 enrolled
The Efficacy of Scalp Block in Craniotomy
Completed·—·Phase 1·NCT06951230·20 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)